These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 11215321)

  • 41. Assessment of the bioequivalence of two formulations of clarithromycin extended-release 500-mg tablets under fasting and fed conditions: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy Jordanian male volunteers.
    Alkhalidi BA; Tamimi JJ; Salem II; Ibrahim H; Sallam AA
    Clin Ther; 2008 Oct; 30(10):1831-43. PubMed ID: 19014838
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Relative bioavailability of fluoride from monofluorophosphate tablets after single oral administration.
    Setnikar I; Maurer H
    Arzneimittelforschung; 1990 Mar; 40(3):323-8. PubMed ID: 2346544
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Saquinavir 500 mg film-coated tablets demonstrate bioequivalence to saquinavir 200 mg hard capsules when boosted with twice-daily ritonavir in healthy volunteers.
    Bittner B; Riek M; Holmes B; Grange S
    Antivir Ther; 2005; 10(7):803-10. PubMed ID: 16312177
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Absolute bioavailability of folic acid after oral administration of a folic acid tablet formulation in healthy volunteers].
    Menke A; Weimann HJ; Achtert G; Schuster O; Menke G
    Arzneimittelforschung; 1994 Sep; 44(9):1063-7. PubMed ID: 7986245
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of the pharmacokinetics of ticlopidine between administration of a combined fixed-dose tablet formulation of ticlopidine 250 mg/ginkgo extract 80 mg, and concomitant administration of ticlopidine 250-mg and ginkgo extract 80-mg tablets: an open-label, two-treatment, single-dose, randomized-sequence crossover study in healthy Korean male volunteers.
    Kim TE; Kim BH; Kim J; Kim KP; Yi S; Shin HS; Lee YO; Lee KH; Shin SG; Jang IJ; Yu KS
    Clin Ther; 2009 Oct; 31(10):2249-57. PubMed ID: 19922896
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Results of a single-center, single-dose, randomized-sequence, open-label, two-way crossover bioequivalence study of two formulations of valsartan 160-mg tablets in healthy volunteers under fasting conditions.
    Spínola AC; Almeida S; Filipe A; Neves R; Trabelsi F; Farré A
    Clin Ther; 2009 Sep; 31(9):1992-2001. PubMed ID: 19843489
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharmacokinetic properties of combination oxycodone plus racemic ibuprofen: two randomized, open-label, crossover studies in healthy adult volunteers.
    Kapil R; Nolting A; Roy P; Fiske W; Benedek I; Abramowitz W
    Clin Ther; 2004 Dec; 26(12):2015-25. PubMed ID: 15823765
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of two marketed nifedipine modified-release formulations: an exploratory clinical food interaction study.
    Wonnemann M; Schug B; Anschütz M; Brendel E; De Nucci G; Blume H
    Clin Ther; 2008 Jan; 30(1):48-58. PubMed ID: 18343242
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparative bioavailability of 2 tablet formulations of levodopa/benserazide in healthy, fasting volunteers: a single-dose, randomized-sequence, open-label crossover study.
    Keller GA; Czerniuk P; Bertuola R; Spatz JG; Assefi AR; Di Girolamo G
    Clin Ther; 2011 Apr; 33(4):500-10. PubMed ID: 21635995
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmacokinetics and relative bioavailability of prajmalium bitartrate after single oral dosing.
    Breuel HP; Weimann HJ; Dahmen W; Hausleiter HJ; Bondy S
    Arzneimittelforschung; 1991 Dec; 41(12):1222-5. PubMed ID: 1815520
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [The pharmacokinetics of dihydroergocristine after intravenous and oral administration in rats].
    Grognet JM; Rivière R; Istin M; Zanotti A; Coppi G
    Arzneimittelforschung; 1992 Nov; 42(11A):1394-6. PubMed ID: 1492859
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Bioavailability and selected pharmacokinetic parameters of clindamycin hydrochloride after administration of a new 600 mg tablet formulation.
    Mazur D; Schug BS; Evers G; Larsimont V; Fieger-Büschges H; Gimbel W; Keilbach-Bermann A; Blume HH
    Int J Clin Pharmacol Ther; 1999 Aug; 37(8):386-92. PubMed ID: 10475141
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Bioequivalence study of two azithromycin formulations in healthy subjects.
    Setiawati E; Deniati SH; Yunaidi DA; Handayani LR; Harinanto G; Santoso ID; Sari AP; Rimainar A
    Arzneimittelforschung; 2009; 59(9):471-5. PubMed ID: 19856795
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparative bioavailability of two estazolam tablet formulations in Indonesian healthy volunteers.
    Harahap Y; Sasongko L; Prasaja B; Indriati E; Lusthom W; Lipin
    Arzneimittelforschung; 2008; 58(10):501-4. PubMed ID: 19025059
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Preliminary pharmacokinetic study of ibuprofen enantiomers after administration of a new oral formulation (ibuprofen arginine) to healthy male volunteers.
    Fornasini G; Monti N; Brogin G; Gallina M; Eandi M; Persiani S; Bani M; Della Pepa C; Zara G; Strolin Benedetti M
    Chirality; 1997; 9(3):297-302. PubMed ID: 9176996
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Steady state bioavailability of a new oral formulation of Hydergine in geriatric patients.
    Sörgel F; Abisch E; Dennler HJ; Lang E
    Eur J Clin Pharmacol; 1984; 26(1):133-5. PubMed ID: 6714287
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Single-dose bioavailability of oral and intramuscular thiocolchicoside in healthy volunteers.
    Sandouk P; Bouvier d'Yvoire M; Chretien P; Tillement JP; Scherrmann JM
    Biopharm Drug Dispos; 1994 Jan; 15(1):87-92. PubMed ID: 8161719
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Absorption kinetics of dihydroergotoxine following oral administration to man.
    Woodcock BG; Rietbrock N; Loh W; Habedank WD
    Br J Clin Pharmacol; 1985 Dec; 20(6):603-9. PubMed ID: 4091992
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparative blood level of dihydroergotoxine (DHET) after administration of two oral forms (solution & tablet): a preliminary study.
    Aliache JM; Briot M; Couquelet J; Vigo P
    Eur J Drug Metab Pharmacokinet; 1981; 6(3):221-4. PubMed ID: 7308241
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The absolute systemic availability of a new oral formulation of co-dergocrine in healthy subjects.
    Dominiak P; Grevel J; Abisch E; Grobecker H; Dennler HJ; Welzel D
    Eur J Clin Pharmacol; 1988; 35(1):53-7. PubMed ID: 3146506
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.